Vimarsana
Biggest News Aggregation in the World

Paul Romness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul Romness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Romness Today - Breaking & Trending Today

Team Arnav Foundation Partners with OS Therapies Supporting the Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma - Vimarsana News

Team Arnav Foundation Partners with OS Therapies Supporting the Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma

Published: September 22, 2022

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company and Team Arnav Foundation, a non-profit 501c3 organization focused on...

Source: prnewswire.com
Related Topics:
Paul RomnessDhruv KrishnaTeam Arnav FoundationFounder Of Team Arnav FoundationTeam ArnavOs Therapies IncArnav FoundationClinical TrialResected OsteosarcomaPediatric Osteosarcoma CancerOverall SurvivalRare Disease DesignationOrphan DesignationsBreak Through DesignationOs Therapies
OS Therapies Receives Rare Pediatric Disease Designation (RDD) in Osteosarcoma for OST-HER2 (Listeria monocytogenes) - Vimarsana News

OS Therapies Receives Rare Pediatric Disease Designation (RDD) in Osteosarcoma for OST-HER2 (Listeria monocytogenes)

Published: November 3, 2021

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company whose lead program uses OST-HER2 (Listeria monocytogenes) is being...

Source: prnewswire.com
Related Topics:
United KingdomColin GoddardPaul RomnessDrug AdministrationOs Therapies IncRare Pediatric Disease DesignationPriority Review VoucherRare Disease DesignationExecutive ChairOverall SurvivalOrphan Drug DesignationsBreak Through DesignationOs Therapies